• 제목/요약/키워드: transmembrane

검색결과 596건 처리시간 0.035초

최대 엔트로피 모델을 이용한 막횡단 단백질 예측 (Maximum Entropy Approach to Transmembrane Protein Prediction)

  • 윤성희;차정원;박승수
    • 한국정보과학회:학술대회논문집
    • /
    • 한국정보과학회 2005년도 한국컴퓨터종합학술대회 논문집 Vol.32 No.1 (B)
    • /
    • pp.664-666
    • /
    • 2005
  • 막횡단 단백질(Transmembrane Protein)은 약물표적(drug target)으로 신약개발로 대표되는 바이오 산업에서 중요한 연구대상이 되고 있다. 막횡단 단백질의 구조는 실험적 기법 또는 컴퓨터 모델링 기술을 이용하여 연구되고 있으며 컴퓨터 모델링 방법 중에서는 Hidden Markov Mode(HMM)에 기반한 시스템들이 좋은 성능을 보이고 있다. 그런데 이러한 시스템들은 구조형성에 관여하는 단백질의 다양한 특성에 대한 지식은 많이 고려하고 있지 않다. 만약 이러한 특성들이 고려된다면 구조 예측에 효과적인 보다 지능적인 모델을 만드는데 도움을 줄 수 있을 것이다. 본 논문은 단백질의 특성과 관련한 다양한 정보들을 융합하는데 효율적인 최대엔트로피모델(Maximum Entropy Model)을 이용하여 막횡단 단백질의 서열(sequence)로부터 막횡단 지역을 예측하는 방법을 제시하고자 한다.

  • PDF

Genistein이 T lymphocyte의 Apoptosis 및 복강 Macrophage의 탐식능에 미치는 영향 (Effect of Genistein on Apoptosis of T Iymphocyte and Phagocytosis of Peritoneal Macrophage)

  • 은재순;조선경;이택렬;김대근;오찬호;소준노
    • 약학회지
    • /
    • 제46권1호
    • /
    • pp.69-74
    • /
    • 2002
  • The effects of genistein on murine thymocytes for inducing apoptotic cell death and phagocytic activity of peritoneal macrophage were studied in vitro. Addition of genistein (10 and 50$\mu$M) to cultured thymocytes from BALB/c mice definitely promoted DNA fragmentation. Also, cytofluorometric analysis of these cells demonstrated a reduction in mitochondrial transmembrane potential ($\Delta$Ψm). But, repeated administration of genistein (1 mg/mouse/day) to mice for 7 days did not cause any detectable DNA fragmentation. Genistein decreased lucigenin chemiluminescence and engulfment of fluorescein-conjugated E. coli particles in peritoneal macrophage. These results suggest that genistein induce an apoptosis of thymocyte via reduction in $\Delta$Ψm and decrease phagocytic activity of peritoneal macrophage in vitro.

침지형 막모듈에서 중공사 분산에 따른 여과특성 (Filtration Characteristics according to Hollow Fiber Dispersion in Submerged Membrane Module)

  • 이재인;신춘환
    • 한국환경과학회지
    • /
    • 제9권2호
    • /
    • pp.173-176
    • /
    • 2000
  • This study was carried out to investigate the filtration characteristics of membrane modules according to hollow fiber dispersion for direct solid-liquid separation of activated sludge. 2 bundle, 4 bundle, and 10 bundle, and 10 bundle module used in this experiment according to hollow fiber dispersion was manufactured at laboratory and permeate flux and transmembrane pressure(TMP) of each module were observed under a suction pressure of 0.5kgf/c$m^2$. As the hollow fibers were dispersed, permeate flux was increased and TMP was decreased. Permeate flux and TMP of each module was 15.0 $\ell$/$m^2$.h and 31.8 cmHg for 2 bundle, 16.0 $\ell$/$m^2$ .h and 17.4 cmHg for 4 bundle, and 20.4 $\ell$/m2 .h and 31.8 cmHg for 10 bundle. In conclusion, the membrane fouling is expected to be decrease by maintaining lower TMP with hollow fiber dispersion.

  • PDF

Glycyrrhizin이 Mel/ret transgenic mice에서의 melanoma 세포의 apoptosis에 미치는 영향 (Effect of Glycyrrhizin on the Aoptosis of Melanoma Cells in Mel/ret Transgenic Mice)

  • 오찬호;염정열
    • KSBB Journal
    • /
    • 제13권6호
    • /
    • pp.718-723
    • /
    • 1998
  • The effect of glycyrrhizin on melanoma cells was investigated. DNA fragmentation in cultured melanoma cells was promoted by the addition of glycyrrhizin in a dose dependent manner. Administration(i.m.) of glycyrrhizin to Mel/ret transgenic mice resulted in apoptosis induction, reduction of mitochondrial transmembrane potential in melanoma cells. Decreased B220+ B cells were recovered by the treatment of glycyrrhizin in splenocytes and mesenteric lymph node cells, while Thy-1+ T cells were not influenced. Results suggested that glycyrrhizin acted as an inducer of apoptosis of melanoma cells and an immuno-potentiator via recovered B lymphocyte population in Mel/ret transgenic mice.

  • PDF

Microfiltration Helical Module들에서 Hollow Fiber의 Diameter과 Curvature 및 Turn수의 변화에 따른 성능변화에 관한 연구 (The Effect of the Variation of Hollow Fiber Diameter and Curvature and Turn Number on Performance for Microfiltration Helical Modules)

  • 이광현
    • 멤브레인
    • /
    • 제7권2호
    • /
    • pp.84-94
    • /
    • 1997
  • Hollow fiber의 diameter와 curvature 및 turn수 등의 변화에 따른 첫번째 모듈 set와 두번째 모듈 set 사이의 성능비교가 이루어졌다. 모든 실험들은 같은 transmembrane pressure와 막면적당 에너지 소모하에서 수행되었다. 첫번째 모듈 set에 대해서 Dean vortices에 의한 농도분극과 막오염현상의 감소시키는 효과가 매우 작음을 알 수 있었다. 두번째 모듈 set에 대해서 115%의 투과 flux 향상값 (투과 flux 증분 ${\times}100$/선형 모듈의 투과 flux)을 보였다. 이로부터 두번째 모듈 set가 yeast suspension에 의한 농도분극과 막오염현상의 감소에 훨씬 효과적임을 알 수 있었다.

  • PDF

COD removal from industrial wastewater plants using reverse osmosis membrane

  • Madaeni, S.S.;Samieirad, S.
    • Membrane and Water Treatment
    • /
    • 제1권4호
    • /
    • pp.273-282
    • /
    • 2010
  • Treatment and reuse of industrial wastewater is becoming a major goal due to water scarcity. This may be carried out using membrane separation technology in general and reverse osmosis (RO) in particular. In the current study, polyamide (FT-30) membrane was employed for treatment of wastewater obtained from Faraman industrial zone based in Kermanshah (Iran). The effects of operating conditions such as transmembrane pressure, cross flow velocity, temperature and time on water flux and rejection of impurities including COD by the membrane were elucidated. The aim was an improvement in membrane performance. The results indicate that most of the chemical substances are removed from the wastewater. In particular COD removal was increased from 64 to around 100% as temperature increased from 15 to $45^{\circ}C$. The complete COD removal was obtained at transmembrane pressure of 20 bars and cross flow velocity of 1.5 m/s. The treated wastewater may be reused for various applications including makeup water for cooling towers.

Membrane distillation of power plant cooling tower blowdown water

  • Ince, Elif;Uslu, Yasin Abdullah
    • Membrane and Water Treatment
    • /
    • 제10권5호
    • /
    • pp.321-330
    • /
    • 2019
  • The objective of this study was to examine the recovery of the power plant cooling tower blowdown water (CTBD) by membrane distillation. The experiments were carried out using a flat plate poly vinylidene fluoride (PVDF) membrane with a pore diameter of $0.22{\mu}m$ by a direct contact membrane distillation unit (DCMD). The effects of operating parameters such as transmembrane temperature difference (${\Delta}T$), circulation rate and operating time on permeate flux and membrane fouling have been investigated. The results indicated that permeate flux increased with increasing ${\Delta}T$ and circulation rate. Whereas maximum permeate flux was determined as $47.4L/m^2{\cdot}h$ at ${\Delta}T$ of $50^{\circ}C$ for all short term experiments, minimum permeate flux was determined as $7.7L/m^2{\cdot}h$ at ${\Delta}T$ of $20^{\circ}C$. While $40^{\circ}C$ was determined as the optimum ${\Delta}T$ in long term experiments. Inorganic and non-volatile substances caused fouling in the membranes.

Antisense Oligonucleotide Therapeutics for Cystic Fibrosis: Recent Developments and Perspectives

  • Young Jin Kim;Adrian R. Krainer
    • Molecules and Cells
    • /
    • 제46권1호
    • /
    • pp.10-20
    • /
    • 2023
  • Antisense oligonucleotide (ASO) technology has become an attractive therapeutic modality for various diseases, including Mendelian disorders. ASOs can modulate the expression of a target gene by promoting mRNA degradation or changing pre-mRNA splicing, nonsense-mediated mRNA decay, or translation. Advances in medicinal chemistry and a deeper understanding of post-transcriptional mechanisms have led to the approval of several ASO drugs for diseases that had long lacked therapeutic options. For instance, an ASO drug called nusinersen became the first approved drug for spinal muscular atrophy, improving survival and the overall disease course. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause cystic fibrosis (CF). Although Trikafta and other CFTR-modulation therapies benefit most CF patients, there is a significant unmet therapeutic need for a subset of CF patients. In this review, we introduce ASO therapies and their mechanisms of action, describe the opportunities and challenges for ASO therapeutics for CF, and discuss the current state and prospects of ASO therapies for CF.